Drugs / CJ-15314
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04297865 | Feb 2020 → Jan 2021 | — | HK inno.N Corporation | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CJ-15314 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04297865 ↗ |
| Known as | CJ-15314 phosphate | “This study aims to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of CJ-15314 phosphate in healthy male subjects” NCT04297865 ↗ |
| Route | Oral | “Oral administration of A as CJ-15314 or placebo once a day” NCT04297865 ↗ |